Alternative Name: GES VR
Description: A vaginal ring, made of silastic and containing gestodene.
Delivery Method: Vaginal Ring
Duration Type: Long-acting
Duration: One year
Dose: 25 mg
Active Pharmaceutical Ingredient (API):
Inactive material: silastic
Multipurpose Preventive Technology (MPT): No
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Began discovery in: 2007
Active Development: Unknown
- All preclinical research work has been finished. Once approval is granted by SFDA (China), the clinical trial will start.